Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of PROTACs for targeted degradation of oncogenic TRK fusions. | RSC Chem Biol | 2026 | 41908584 | PubTator, text mining | PubMed |
| Structural basis of odorant recognition by a mammalian class II odorant receptor. | Sci Adv | 2026 | 41894497 | PubTator, text mining | PubMed |
| TRPtracker: a community database for monitoring praziquantel sensitivity at TRPMPZQ variants. | Int J Parasitol Drugs Drug Resist | 2026 | 41865684 | PubTator, text mining | PubMed |
| Structural basis for prostaglandin and drug transport via SLCO2A1. | Nat Commun | 2026 | 41862483 | PubTator, text mining | PubMed |
| Molecular Modeling and Dynamics of a Complete Connexin-43 Gap Junction Channel in Various Phosphorylation States. | J Phys Chem B | 2026 | 41837330 | PubTator, text mining | PubMed |
| HIF-1-regulated TPM3 links hypoxia to motility and invasion beyond the hypoxic fraction in triple-negative breast cancer. | NPJ Breast Cancer | 2026 | 41832172 | PubTator, text mining | PubMed |
| Computational modelling of the equine arteritis virus GP5/M Dimer: Implications for immune evasion and virulence. | PLoS One | 2026 | 41805756 | PubTator, text mining | PubMed |
| Targeted therapy for ALK-positive histiocytosis masquerading as optic nerve tumor: a case report. | Childs Nerv Syst | 2026 | 41803275 | PubTator, text mining | PubMed |
| IFI44 Promotes Clear Cell Renal Cell Carcinoma Progression via PRDX1 and Predicts Poor Prognosis. | Research (Wash D C) | 2026 | 41799288 | PubTator, text mining | PubMed |
| Uncovering Clinically Relevant Breast Cancer Subtypes Biomarkers Using Integrative Bioinformatics and Machine Learning Approaches. | Biomarkers | 2026 | 41797509 | PubTator, text mining | PubMed |
| Identification of MTURN as a trained immunity-related biomarker for heart failure via integrative transcriptomic machine learning analysis and experimental validation. | Front Immunol | 2026 | 41789108 | PubTator, text mining | PubMed |
| Differentially expressed proteins in plasma-derived extracellular vesicles from chronic myeloid leukemia patients. | Front Genet | 2026 | 41773228 | PubTator, text mining | PubMed |
| pH-Driven β2AR Dynamics Reveal Loop-Mediated Allosteric Communication. | ACS Omega | 2026 | 41768732 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals the mechanistic role of lactate metabolism in the pancreatic ductal adenocarcinoma microenvironment. | Front Immunol | 2026 | 41766855 | PubTator, text mining | PubMed |
| Takotsubo Syndrome: The First Non-Acute Proteomic Analysis by Remote Dried Blood Microsampling. | J Cardiovasc Transl Res | 2026 | 41760974 | PubTator, text mining | PubMed |
| Structural evolution of the MTCH family of mitochondrial insertases. | bioRxiv | 2026 | 41757004 | PubTator, text mining | PubMed |
| Genomic Profile of Non-Small Cell Lung Cancer in a Spanish Cohort: A 2-Year Descriptive Study Using Next-Generation Sequencing. | Genes (Basel) | 2026 | 41751593 | PubTator, text mining | PubMed |
| Single-Cell Multi-Omics Profiling of Human Septal Myectomy Tissue: Toward Precision Medicine in Obstructive Hypertrophic Cardiomyopathy. | J Pers Med | 2026 | 41745380 | PubTator, text mining | PubMed |
Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment. | Open Life Sci | 2026 | 41737604 | PubTator, text mining | PubMed |
| Discovery of a Novel Phenyl Thiophene-3-carboxamide Derivative DZX19 as an Orally TRK Inhibitor with Potent Antitumor Effects. | J Med Chem | 2026 | 41736461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=2